Cantor Fitzgerald Estimates ADMA Biologics FY2025 Earnings
ADMA Biologics Inc (NASDAQ:ADMA – Free Report) – Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for ADMA Biologics in a report issued on Wednesday, June 25th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will earn $0.61 per share for the year, down from their prior […]
